A Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome


Original post, click here

Conditions:   Acute Myeloid Leukemia;   Myelodysplastic Syndromes;   Relapsed Cancer;   Refractory Cancer
Intervention:   Drug: CFI-400945 Fumarate
Sponsor:   University Health Network, Toronto
Not yet recruiting – verified June 2017